{"id":"W3129382481","doi":"10.2217/cer-2020-0267","title":"Efficacy classification of modern therapies in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Cladribine; Ofatumumab; Multiple sclerosis; Relapsing remitting; Internal medicine; Placebo; MEDLINE; Oncology; Intensive care medicine; Alternative medicine; Rituximab; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0553828,0.001156044,0.003749394,0.008147874,0.0005347963,0.002613311,0.001307612,0.001123499,0.003633327],"category_scores_gemma":[0.08289308,0.000407278,0.007011062,0.003536496,0.001865795,0.001871808,0.001538576,0.001947547,0.0003210892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002127108,"about_ca_system_score_gemma":0.001128586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009961909,"about_ca_topic_score_gemma":0.001349092,"domain_scores_codex":[0.9325558,0.04318252,0.009858851,0.003308215,0.01049782,0.0005968122],"domain_scores_gemma":[0.8721541,0.09136452,0.02502841,0.005113975,0.00561855,0.0007204478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03989511,0.0006752434,0.1605247,0.1144985,0.1151836,0.0001325335,0.001391773,0.006329713,0.002005502,0.01204024,0.01092627,0.5363967],"study_design_scores_gemma":[0.02413554,0.02349618,0.5245421,0.08208317,0.1689679,0.002180058,0.001423701,0.02225754,0.005922892,0.06977984,0.07459337,0.0006176805],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1236235,0.8322057,0.01723224,0.005918981,0.001506867,0.002276578,0.005425417,0.0001384179,0.01167239],"genre_scores_gemma":[0.9157778,0.0495456,0.02649799,0.002196208,0.001705001,0.001568768,0.002061653,0.00005556056,0.0005913571],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0553828,"threshold_uncertainty_score":0.2928957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.436733189315095,"score_gpt":0.4796674318923596,"score_spread":0.04293424257726453,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}